NO880186D0 - Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav. - Google Patents

Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.

Info

Publication number
NO880186D0
NO880186D0 NO1988880186A NO880186A NO880186D0 NO 880186 D0 NO880186 D0 NO 880186D0 NO 1988880186 A NO1988880186 A NO 1988880186A NO 880186 A NO880186 A NO 880186A NO 880186 D0 NO880186 D0 NO 880186D0
Authority
NO
Norway
Prior art keywords
tetrapeptime
inhibitor
procedure
preparation
tetrapeptime inhibitor
Prior art date
Application number
NO1988880186A
Other languages
English (en)
Other versions
NO880186L (no
NO173655B (no
NO173655C (no
Inventor
Emilia Findel
Maryse Lenfant
Martine Guigon
Johanna Bakala
Original Assignee
Inst Nat Sante Rech Med
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8610486A priority Critical patent/FR2601678B1/fr
Priority to US07/313,972 priority patent/US5114926A/en
Priority to PCT/FR1987/000281 priority patent/WO1988000594A1/fr
Priority to JP62504351A priority patent/JP2542407B2/ja
Priority to EP87904695A priority patent/EP0316322B1/fr
Priority to AU10261/88A priority patent/AU598897B2/en
Priority to CA000556648A priority patent/CA1337731C/en
Application filed by Inst Nat Sante Rech Med, Roussy Inst Gustave filed Critical Inst Nat Sante Rech Med
Priority to NO880186A priority patent/NO173655C/no
Publication of NO880186D0 publication Critical patent/NO880186D0/no
Publication of NO880186L publication Critical patent/NO880186L/no
Priority to NO930799A priority patent/NO175102C/no
Priority claimed from NO930799A external-priority patent/NO175102C/no
Publication of NO173655B publication Critical patent/NO173655B/no
Publication of NO173655C publication Critical patent/NO173655C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO880186A 1986-07-18 1988-01-18 Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale NO173655C (no)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8610486A FR2601678B1 (fr) 1986-07-18 1986-07-18 Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
PCT/FR1987/000281 WO1988000594A1 (fr) 1986-07-18 1987-07-16 Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopoietiques, procedes pour son obtention et ses applications
JP62504351A JP2542407B2 (ja) 1986-07-18 1987-07-16 新規テトラペプチド、その製法ならびにその用途
EP87904695A EP0316322B1 (fr) 1986-07-18 1987-07-16 Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopo etiques, procedes pour son obtention et ses applications
US07/313,972 US5114926A (en) 1986-07-18 1987-07-16 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses
AU10261/88A AU598897B2 (en) 1986-07-18 1988-01-14 Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation, and its uses
CA000556648A CA1337731C (en) 1986-07-18 1988-01-15 Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation and its uses
NO880186A NO173655C (no) 1986-07-18 1988-01-18 Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale
NO930799A NO175102C (no) 1986-07-18 1993-03-04 Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR8610486A FR2601678B1 (fr) 1986-07-18 1986-07-18 Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
PCT/FR1987/000281 WO1988000594A1 (fr) 1986-07-18 1987-07-16 Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopoietiques, procedes pour son obtention et ses applications
AU10261/88A AU598897B2 (en) 1986-07-18 1988-01-14 Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation, and its uses
NO880186A NO173655C (no) 1986-07-18 1988-01-18 Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale
NO930799A NO175102C (no) 1986-07-18 1993-03-04 Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH

Publications (4)

Publication Number Publication Date
NO880186D0 true NO880186D0 (no) 1988-01-18
NO880186L NO880186L (no) 1989-07-19
NO173655B NO173655B (no) 1993-10-04
NO173655C NO173655C (no) 1994-01-12

Family

ID=27422438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880186A NO173655C (no) 1986-07-18 1988-01-18 Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale

Country Status (7)

Country Link
US (1) US5114926A (no)
EP (1) EP0316322B1 (no)
JP (1) JP2542407B2 (no)
AU (1) AU598897B2 (no)
FR (1) FR2601678B1 (no)
NO (1) NO173655C (no)
WO (1) WO1988000594A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
US5516891A (en) * 1992-06-16 1996-05-14 Kinerton, Ltd. Liquid phase synthesis of peptides and peptide derivatives
US5739110A (en) * 1994-09-12 1998-04-14 Biomeasure Inc. Protection of hemopoietic cells
US5595973A (en) * 1994-09-12 1997-01-21 Biomeasure Incorporated Protection of hemopoietic cells during chemotherapy or radiotherapy
CA2244673A1 (en) * 1996-02-01 1997-08-07 Josiane Thierry Peptide inhibitors of hematopoietic cell proliferation
WO1997034627A2 (en) * 1996-03-19 1997-09-25 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. Protection of hemopoietic cells during chemotherapy or radiotherapy
US20060194315A1 (en) * 2003-03-31 2006-08-31 Condie Brian G Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
FR2872040B1 (fr) 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
FR2882256B1 (fr) * 2005-02-18 2007-05-25 Centre Nat Rech Scient Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent pour ralentir la chute des cheveux et/ou stimuler leur croissance
US9428552B2 (en) 2012-11-19 2016-08-30 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
FR3120794B1 (fr) 2021-03-16 2023-11-24 Rpm Dermatologie Composition pour injection comprenant un conjugué peptidique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045598A (ja) * 1983-04-07 1985-03-12 エフ．ホフマン−ラ　ロシユ　ウント　コンパニ−　アクチエンゲゼルシヤフト トリチウム化サイモシンβ４による免疫定量法
JPS608226A (ja) * 1983-06-28 1985-01-17 Otsuka Pharmaceut Co Ltd 低分子蛋白質を有効成分とする制ガン剤
JPS6185399A (ja) * 1984-10-02 1986-04-30 Otsuka Pharmaceut Co Ltd Ｔｎｆ開連ペプチド
WO1986002381A1 (en) * 1984-10-15 1986-04-24 Cetus Corporation Human tumor necrosis factor

Also Published As

Publication number Publication date
US5114926A (en) 1992-05-19
AU598897B2 (en) 1990-07-05
NO880186L (no) 1989-07-19
NO173655B (no) 1993-10-04
AU1026188A (en) 1989-07-27
FR2601678B1 (fr) 1989-11-24
EP0316322A1 (fr) 1989-05-24
JP2542407B2 (ja) 1996-10-09
JPH02500269A (ja) 1990-02-01
FR2601678A1 (fr) 1988-01-22
WO1988000594A1 (fr) 1988-01-28
NO173655C (no) 1994-01-12
EP0316322B1 (fr) 1992-09-09

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO863223D0 (no) Sikteanordning og fremgangsmaate ved sikting.
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
DK609689A (da) Folielaminat og dets anvendelse
DK163984C (da) Dampmodificeret krystallinsk galloaluminosilicat, fremgangsmaade til dets fremstilling samt dets anvendelse
DK430683A (da) Humant immuninterferonprotein samt dets fremstilling og anvendelse
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
IT8720296A0 (it) Procedimento e dispositivo per cordonare.
NO893748L (no) Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling.
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
NO880186D0 (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
NO882562D0 (no) Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav.
DK280085A (da) 7alfa-acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner samt deresfremstilling og anvendelse
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
NO883399D0 (no) Angioplastisk kateter og fremgangsmaate for dets bruk.
NO870210D0 (no) Fremgangsmaate og anordning for avskinning.
NO893474L (no) Flammehemmende midler og fremgangsmaate for anvendelse.
DK402685A (da) Alfa-glucosidaseinhibitor, dets fremstilling og anvendelse samt farmaceutiske praeparater
DK35488D0 (da) 3-aryl-5-alkylthio-4h-1,2,4-thiazoler, samt anvendelsen heraf
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO172694C (no) (met)akrylatpolymer, samt anvendelse derav
NO900271D0 (no) Forbindelse og anvendelse.
DK355289A (da) 2,2-dihalogencyclopropyl-hydroxy-ethyltriazoler, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse